Get the Stockscreener App
0.467
30.32%
-0.2032
Harvard Bioscience Inc stock is traded at $0.467, with a volume of 13.25M.
It is down -30.32% in the last 24 hours and up +26.25% over the past month.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.
See More
Previous Close:
$0.6702
Open:
$0.5701
24h Volume:
13.25M
Relative Volume:
1.28
Market Cap:
$20.65M
Revenue:
$106.79M
Net Income/Loss:
$-8.73M
P/E Ratio:
-2.335
EPS:
-0.2
Net Cash Flow:
$10.81M
1W Performance:
+38.91%
1M Performance:
+26.25%
6M Performance:
-78.77%
1Y Performance:
-85.03%
1-Day Range:
$0.4305
$0.5814
1-Week Range:
$0.2813
$0.9458
52-Week Range:
$0.2813
$3.60
Harvard Bioscience Inc Stock (HBIO) Company Profile
Name
Harvard Bioscience Inc
Sector
Industry
Phone
(508) 893-8999
Address
84 OCTOBER HILL RD, HOLLISTON, MA
Compare HBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.467 | 14.86M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
552.34 | 193.38B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
172.59 | 49.12B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.94 | 42.79B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
244.79 | 35.61B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.50 | 15.46B | 11.89B | -560.00M | 191.00M | -1.10 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Mar-10-23 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Jan-07-21 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-09-20 | Initiated | Northland Capital | Outperform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jul-08-19 | Downgrade | Janney | Buy → Neutral |
| Jan-24-18 | Reiterated | Janney | Buy |
| Jan-23-18 | Reiterated | The Benchmark Company | Buy |
| Nov-17-16 | Initiated | Singular Research | Buy |
| Jul-28-15 | Initiated | The Benchmark Company | Buy |
View All
Harvard Bioscience Inc Stock (HBIO) Latest News
Little Excitement Around Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Revenues As Shares Take 26% Pounding - simplywall.st
Harvard Bioscience First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Harvard Bioscience price target lowered to $3 from $4.50 at Benchmark - Yahoo Finance
Harvard Bioscience outlines Q2 revenue target of $18M–$20M amid product launches and cost actions - MSN
Harvard Bioscience (HBIO): Analyst Lowers Price Target, Maintains Rating | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience (HBIO) Target Price Reduced Amid Market Chall - GuruFocus
Harvard Bioscience, Inc. (NASDAQ:HBIO) Q1 2025 Earnings Call Transcript - Insider Monkey
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations - GuruFocus
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast By Investing.com - Investing.com South Africa
Harvard Bioscience Announces First Quarter 2025 Financial Results - GlobeNewswire
Harvard Bioscience: Q1 Earnings Snapshot - MySA
Harvard Bioscience (HBIO) Reports Q1 2025 Highlights Amid Financ - GuruFocus
Harvard Bioscience Q1 2025 Earnings Call Transcript - MarketBeat
Transcript : Harvard Bioscience, Inc., Q1 2025 Earnings Call, May 12, 2025 - marketscreener.com
Harvard Bioscience earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
HBIO Reports Decline in Q1 Revenue Amid Market Challenges | HBIO Stock News - GuruFocus
Harvard Bioscience earnings matched, revenue topped estimates - Investing.com
Harvard Bioscience Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Harvard Bioscience, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HBIO) - Seeking Alpha
Harvard Bioscience Q1 2025 slides: Revenue decline and goodwill impairment weigh on results - Investing.com Canada
Earnings call transcript: Harvard Bioscience Q1 2025 revenue beats forecast - Investing.com
Harvard Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceed - GuruFocus
Harvard Bioscience Inc Reports Q1 2025 Revenue of $21.8M, Exceeding Estimates; Faces Net Loss Due to Goodwill Impairment - GuruFocus
Harvard Bioscience Q1 Net Income USD -50.34 Million - marketscreener.com
Harvard Bioscience Announces First Quarter 2025 Financial Results | HBIO Stock News - GuruFocus
Harvard Bioscience : Q1 2025 Harvard Bioscience, Inc. Earnings Conference Call - marketscreener.com
Harvard Bioscience Inc (HBIO) Q1 2025 Earnings Report Preview: W - GuruFocus
What Is Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Share Price Doing? - Yahoo Finance
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET | HBIO Stock News - GuruFocus
Harvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025 - Nasdaq
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at - Bluefield Daily Telegraph
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET - GlobeNewswire
Harvard Bioscience Sets Date for Q1 2025 Financial Results: What Investors Should Watch - Stock Titan
Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET - IT Business Net
Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)? - simplywall.st
Harvard Bioscience (NASDAQ:HBIO) Coverage Initiated at StockNews.com - American Banking and Market News
Press Release Distribution & PR Platform - ACCESS Newswire
Harvard Bioscience Inc [HBIO] Shares Rise 1.22 % on Wednesday - knoxdaily.com
Did Harvard Bioscience Inc (HBIO) perform well in the last session? - uspostnews.com
Market Watch: Harvard Bioscience Inc (HBIO)’s Noteworthy Gain, Closing at 0.40 - DWinneX
Harvard Bioscience’s Bertrand Loy to Step Down - TipRanks
Harvard Bioscience Inc Stock (HBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.66%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):